CD336 (NKp44) Antibody, anti-human, REAfinity™
Clone:
REA1163
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
FC, MC
Alternative names:
NCR2, LY95, NKp44

Specifications for CD336 (NKp44) Antibody, anti-human, REAfinity™

Overview

Clone REA1163 recognizes the human CD336 antigen, also known as NKp44. CD336 is a member of the natural cytotoxicity receptor (NCR) family which trigger cytotoxicity in natural killer (NK) cells. CD336 is directly involved in target cell recognition and lysis and is only expressed by activated NK cells, e.g., NK cells cultured in the presence of interleukin 2 (IL-2). Freshly isolated, resting NK cells do not express CD336.
Additional information: Clone REA1163 displays negligible binding to Fc receptors.

Alternative names

NCR2, LY95, NKp44

Detailed product information

Technical specifications

CloneREA1163
Clonalitymonoclonal
Isotyperecombinant human IgG1
Isotype controlREA Control Antibody (S), human IgG1
Hosthuman cell line
Type of antibodyPrimary antibodies, Recombinant antibodies
Specieshuman
AntigenCD336 (NKp44)
Alternative names of antigenNCR2, LY95, NKp44
Molecular mass of antigen [kDa]28
Distribution of antigenNK cells, T cells
Entrez Gene ID9436
RRIDAB_2784142, AB_2784139, AB_2784138, AB_2784145, AB_2784144, AB_2784147, AB_2784146, AB_2784141, AB_2784140, AB_2889560, AB_2784143

Resources for CD336 (NKp44) Antibody, anti-human, REAfinity™

Certificates

Please follow this
link
to search for Certificates of Analysis (CoA) by lot number.

References for CD336 (NKp44) Antibody, anti-human, REAfinity™

Publications

  1. Vitale, M. et al. (1998) NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187: 2065-2072
  2. Sivori, S. et al. (2000) 2B4 functions as a co-receptor in human NK cell activation. Eur. J. Immunol. 30: 787-793
  3. Moretta, A. et al. (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19: 197-223
  4. Chaput, N. et al. (2013)
    Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR
    +
    NK cell levels correlate with disease outcome.
    Oncoimmunology 2(2): e23080

Related products for
CD336 (NKp44) Antibody, anti-human, REAfinity™

6 products available | view all
 

REA Control Antibody (S), human IgG1, REAfinity™

The REA Control (S) antibody clone REA293 is a universal isotype control that can be used with all ...

130-050-201

CD14 MicroBeads, human

CD14 MicroBeads can be used for the positive selection or depletion of human monocytes and ...

130-050-401

CD56 MicroBeads, human

CD56 MicroBeads were developed for the positive selection or depletion of natural killer (NK) cells ...

130-104-693

MACS
®
Comp Bead Kit, anti-REA

The MACS® Comp Bead Kits have been developed for optimal compensation of the fluorescence spillover ...

130-099-887

Tandem Signal Enhancer, human

The Tandem Signal Enhancer, human increases binding specificity of tandem dye–conjugated antibodies ...

Seems like you are coming from USA!
Do you want to visit our website in your country?

Copyright © 2023 Miltenyi Biotec and/or its affiliates. All rights reserved.